林春草, 陈大伟, 戴均贵*. 黄酮类化合物合成生物学研究进展J. 药学学报, 2022,57(5): 1322-1335. doi: 10.16438/j.0513-4870.2022-0008
引用本文: 林春草, 陈大伟, 戴均贵*. 黄酮类化合物合成生物学研究进展J. 药学学报, 2022,57(5): 1322-1335. doi: 10.16438/j.0513-4870.2022-0008
LIN Chun-cao, CHEN Da-wei, DAI Jun-gui*. Advances of synthetic biology of flavonoidsJ. Acta Pharmaceutica Sinica, 2022,57(5): 1322-1335. doi: 10.16438/j.0513-4870.2022-0008
Citation: LIN Chun-cao, CHEN Da-wei, DAI Jun-gui*. Advances of synthetic biology of flavonoidsJ. Acta Pharmaceutica Sinica, 2022,57(5): 1322-1335. doi: 10.16438/j.0513-4870.2022-0008

黄酮类化合物合成生物学研究进展

Advances of synthetic biology of flavonoids

  • 摘要: 黄酮类化合物是植物中广泛分布的一大类次级代谢产物,已报道的化合物超过10 000种,结构多样且部分具有抗癌、抗炎等重要的药理活性。黄酮类化合物生物合成相关的基因及酶、生物合成途径解析已有诸多报道;近年来,其合成生物学研究亦取得了较大进展。本文在概述黄酮类化合物生物合成的基础上,对近20年(2001~2021年)报道的黄酮类化合物合成生物学研究进展进行了综述,介绍了代表性黄酮类化合物的细胞工厂创建概况,并对相应的代谢瓶颈及优化策略进行了讨论和展望。

     

    Abstract: Flavonoids is one of the biggest families of the plant-derived secondary metabolites with structural diversity. Until now, over 10 000 kinds of flavonoids with distinct structures have been purified and identified from plants, and some of them possess a range of important pharmacological effects, such as anticancer, anti-inflammatory and so on. So far, a number of genes and enzymes responsible for the biosynthesis of flavonoids have been reported, especially, a great of progress has been achieved in the synthetic biology of flavonoids in the recent years. Herein, based upon a brief introduction on the biosynthesis of flavonoids, this review summarizes the research advances in synthetic biology of flavonoids in the past two decades (2001-2021), highlighting the cell factories construction of the representative flavonoids. And, a brief discussion and prospects of the relevant metabolic bottlenecks and optimizing strategies are proposed.

     

/

返回文章
返回